NIH funds research to improve genomics for Black kids

By staff writers

July 6, 2020 -- The Children's Hospital of Philadelphia is one of the recipients of a multimillion-dollar grant from the U.S. National Institutes of Health (NIH) for projects that use genomics to improve risk assessment. The hospital will use the funding to improve genetic risk assessment for Black children and their families.

The funding was awarded to the hospital's Center for Applied Genomics as part of the NIH's Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network. This is the eighth consecutive year the center has received eMERGE funding.

The Center for Applied Genomics will use the new funding to generate and validate polygenic risk scores to help clinicians analyze a patient's specific disease risk based on their genetics. They will also explore ways to incorporate those risk scores into electronic health records and to develop best practice guidelines for informing children and their families of risk assessment results.

In addition, the center will recruit 2,5000 new participants, with at least 75% of those participants being Black. The center will run and return risk assessments for participants, including assessments of health outcomes for key disease areas.

NIH plan targets new COVID-19 tests, point-of-care options
The National Institutes of Health (NIH) has unveiled an initiative to speed the development and commercialization of COVID-19 testing products and technologies...
NIH begins antibody study on undetected coronavirus cases
The National Institutes of Health (NIH) has commenced a study to determine how many adults in the U.S. with no confirmed history of infection with SARS-CoV-2...
New NIH study pinpoints how coronavirus attacks cells
The continued spread of the novel 2019 coronavirus, known as SARS-CoV-2, around the world has raised the need for a test to rapidly and efficiently screen...
NIH offers update on coronavirus outbreak
The U.S. National Institutes of Health (NIH) has weighed in on the outbreak of the deadly coronavirus in China, with officials discussing the agency's...
NIH-funded Lyme test promises better results, at the point of care
A rapid microfluidics assay for Lyme disease performed better than a standard lab workup and shows promise for use as a single diagnostic test at the...

Copyright © 2020

Last Updated ls 7/6/2020 9:02:36 AM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.